BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 36626212)

  • 1. The Impact of Residual Retinal Fluid Following Intravitreal Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review.
    Patil NS; Mihalache A; Dhoot AS; Popovic MM; Muni RH; Kertes PJ
    Ophthalmic Surg Lasers Imaging Retina; 2023 Jan; 54(1):50-58. PubMed ID: 36626212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longer-Term Anti-VEGF Therapy Outcomes in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Vein Occlusion-Related Macular Edema: Clinical Outcomes in 130 247 Eyes.
    Ciulla TA; Hussain RM; Taraborelli D; Pollack JS; Williams DF
    Ophthalmol Retina; 2022 Sep; 6(9):796-806. PubMed ID: 35381391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of a Machine-Learning Computational Image Analysis Algorithm in Retinal Fluid Quantification for Patients With Diabetic Macular Edema and Retinal Vein Occlusions.
    Song W; Kaakour AH; Kalur A; Muste JC; Iyer AI; Valentim CCS; Singh RP
    Ophthalmic Surg Lasers Imaging Retina; 2022 Mar; 53(3):123-131. PubMed ID: 35272558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta-Analysis.
    Mihalache A; Hatamnejad A; Patil NS; Popovic MM; Kertes PJ; Cruz-Pimentel M; Muni RH
    Ophthalmologica; 2024; 247(1):19-29. PubMed ID: 37579730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of a Treat-and-Extend Regimen of Anti-Vascular Endothelial Growth Factor Agents for Diabetic Macular Edema or Macular Edema Secondary to Retinal Vein Occlusion: A Systematic Review and Meta-Analysis.
    Patil NS; Dhoot AS; Nichani PAH; Popovic MM; Muni RH; Kertes PJ
    Ophthalmic Surg Lasers Imaging Retina; 2023 Mar; 54(3):131-138. PubMed ID: 36944072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term results of intravitreal bevacizumab for macular edema with retinal vein obstruction and diabetic macular edema.
    Byeon SH; Kwon YA; Oh HS; Kim M; Kwon OW
    J Ocul Pharmacol Ther; 2007 Aug; 23(4):387-94. PubMed ID: 17803438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Serum Inflammation-Based Factors in Anti-Vascular Endothelial Growth Factor Treatment for Macular Edema Secondary to Retinal Vein Occlusion and Its Subtypes.
    Rao J; Wu N; Qu X; Hu Y; Wu Y; Cheng Y; Yan L; Huang H; Li S; Shi L; Wu X
    Ophthalmic Res; 2021; 64(2):237-245. PubMed ID: 32506058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Hyperreflective Dots on Spectral-Domain Optical Coherence Tomography in Macular Edema and Response to Treatment.
    Hwang HS; Chae JB; Kim JY; Kim DY
    Invest Ophthalmol Vis Sci; 2017 Nov; 58(13):5958-5967. PubMed ID: 29183041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4.
    Scott IU; VanVeldhuisen PC; Ip MS; Blodi BA; Oden NL; King J; Antoszyk AN; Peters MA; Tolentino M;
    JAMA Ophthalmol; 2017 Jun; 135(6):639-649. PubMed ID: 28492860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion.
    Babiuch AS; Han M; Conti FF; Wai K; Silva FQ; Singh RP
    JAMA Ophthalmol; 2019 Jan; 137(1):38-46. PubMed ID: 30286219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between Ozurdex and intravitreal anti-vascular endothelial growth factor treatment for retinal vein occlusion-related macular edema: A systematic review and meta-analysis of randomized controlled trials.
    Hu Q; Li H; Xu W; Du Y; Ma C; He J
    Indian J Ophthalmol; 2019 Nov; 67(11):1800-1809. PubMed ID: 31638037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION.
    Lotfy A; Solaiman KAM; Abdelrahman A; Samir A
    Retina; 2018 Sep; 38(9):1795-1800. PubMed ID: 28767552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-dimensional analysis of morphologic changes and visual outcomes in diabetic macular edema.
    Lee H; Kang KE; Chung H; Kim HC
    Jpn J Ophthalmol; 2019 May; 63(3):234-242. PubMed ID: 30783942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual Outcomes Associated With Patterns of Macular Edema Resolution in Central Retinal Vein Occlusion Treated With Anti-Vascular Endothelial Growth Factor Therapy: A Post Hoc Analysis of the Lucentis, Eylea, Avastin in Vein Occlusion (LEAVO) Trial.
    Gurudas S; Patrao N; Nicholson L; Sen P; Ramu J; Sivaprasad S; Hykin P
    JAMA Ophthalmol; 2022 Feb; 140(2):143-150. PubMed ID: 34989804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated quantification of macular fluid in retinal diseases and their response to anti-VEGF therapy.
    Michl M; Fabianska M; Seeböck P; Sadeghipour A; Haj Najeeb B; Bogunovic H; Schmidt-Erfurth UM; Gerendas BS
    Br J Ophthalmol; 2022 Jan; 106(1):113-120. PubMed ID: 33087314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperreflective Foci in Diabetic Macular Edema with Subretinal Fluid: Association with Visual Outcomes after Anti-VEGF Treatment.
    Tang L; Luo D; Qiu Q; Xu GT; Zhang J
    Ophthalmic Res; 2023; 66(1):39-47. PubMed ID: 35697006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual and Anatomic Outcomes following Cataract Surgery in Patients with Pre-operative Macular Edema Due to Retinal Vein Occlusions Managed with Intravitreal anti-VEGF.
    Starr MR; Mahr MA; Iezzi R; Barkmeier AJ; Bakri SJ
    Semin Ophthalmol; 2020 May; 35(4):205-209. PubMed ID: 32721186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectral-Domain OCT Predictors of Visual Outcomes after Ranibizumab Treatment for Macular Edema Resulting from Retinal Vein Occlusion.
    Yiu G; Welch RJ; Wang Y; Wang Z; Wang PW; Haskova Z
    Ophthalmol Retina; 2020 Jan; 4(1):67-76. PubMed ID: 31669329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomic Biomarkers of Macular Edema Associated with Retinal Vein Occlusion.
    Ciulla TA; Kapik B; Hu A; Harris A; Ip MS; Blodi B
    Ophthalmol Retina; 2022 Dec; 6(12):1206-1220. PubMed ID: 35781069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.